Integra LifeSciences Cor... (IART)
Integra LifeSciences Statistics
Share Statistics
Integra LifeSciences has 77.22M shares outstanding. The number of shares has increased by -1.35% in one year.
| Shares Outstanding | 77.22M |
| Shares Change (YoY) | -1.35% |
| Shares Change (QoQ) | -0.54% |
| Owned by Institutions (%) | 90.64% |
| Shares Floating | 66.12M |
| Failed to Deliver (FTD) Shares | 823 |
| FTD / Avg. Volume | 0.12% |
Short Selling Information
The latest short interest is 3.37M, so 4.37% of the outstanding shares have been sold short.
| Short Interest | 3.37M |
| Short % of Shares Out | 4.37% |
| Short % of Float | 5.1% |
| Short Ratio (days to cover) | 6.18 |
Valuation Ratios
The PE ratio is -251.52 and the forward PE ratio is 10.35. Integra LifeSciences's PEG ratio is 2.28.
| PE Ratio | -251.52 |
| Forward PE | 10.35 |
| PS Ratio | 1.08 |
| Forward PS | 0.9 |
| PB Ratio | 1.13 |
| P/FCF Ratio | 69.96 |
| PEG Ratio | 2.28 |
Enterprise Valuation
Integra LifeSciences Corporation has an Enterprise Value (EV) of 4.89B.
| EV / Earnings | -704.66 |
| EV / Sales | 3.04 |
| EV / EBITDA | 25.32 |
| EV / EBIT | 172.23 |
| EV / FCF | 196.01 |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.17 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.14 |
| Total Debt / Capitalization | 12.23 |
| Cash Flow / Debt | 0.6 |
| Interest Coverage | 0.4 |
Financial Efficiency
Return on equity (ROE) is 0% and return on capital (ROIC) is 0.61%.
| Return on Equity (ROE) | 0% |
| Return on Assets (ROA) | 0% |
| Return on Capital (ROIC) | 0.61% |
| Revenue Per Employee | $366,361.92 |
| Profits Per Employee | $-1,579.62 |
| Employee Count | 4,396 |
| Asset Turnover | 0.4 |
| Inventory Turnover | 1.7 |
Taxes
| Income Tax | -11.29M |
| Effective Tax Rate | 0.62 |
Stock Price Statistics
The stock price has increased by -37.94% in the last 52 weeks. The beta is 1.23, so Integra LifeSciences's price volatility has been higher than the market average.
| Beta | 1.23 |
| 52-Week Price Change | -37.94% |
| 50-Day Moving Average | 23.78 |
| 200-Day Moving Average | 23.28 |
| Relative Strength Index (RSI) | 43.69 |
| Average Volume (20 Days) | 664.07K |
Income Statement
In the last 12 months, Integra LifeSciences had revenue of 1.61B and earned -6.94M in profits. Earnings per share was -0.09.
| Revenue | 1.61B |
| Gross Profit | 882.06M |
| Operating Income | 28.41M |
| Net Income | -6.94M |
| EBITDA | 193.29M |
| EBIT | 28.41M |
| Earnings Per Share (EPS) | -0.09 |
Balance Sheet
The company has 246.38M in cash and 215.38M in debt, giving a net cash position of 31M.
| Cash & Cash Equivalents | 246.38M |
| Total Debt | 215.38M |
| Net Cash | 31M |
| Retained Earnings | 939.91M |
| Total Assets | 4.04B |
| Working Capital | 159.56M |
Cash Flow
In the last 12 months, operating cash flow was 129.38M and capital expenditures -104.42M, giving a free cash flow of 24.96M.
| Operating Cash Flow | 129.38M |
| Capital Expenditures | -104.42M |
| Free Cash Flow | 24.96M |
| FCF Per Share | 0.32 |
Margins
Gross margin is 54.77%, with operating and profit margins of 1.76% and -0.43%.
| Gross Margin | 54.77% |
| Operating Margin | 1.76% |
| Pretax Margin | -1.13% |
| Profit Margin | -0.43% |
| EBITDA Margin | 12% |
| EBIT Margin | 1.76% |
| FCF Margin | 1.55% |
Dividends & Yields
IART does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -0.41% |
| FCF Yield | 1.47% |
Analyst Forecast
The average price target for IART is $25, which is 13.6% higher than the current price. The consensus rating is "Hold".
| Price Target | $25 |
| Price Target Difference | 13.6% |
| Analyst Consensus | Hold |
| Analyst Count | 8 |
Stock Splits
The last stock split was on Jan 4, 2017. It was a forward split with a ratio of 2:1.
| Last Split Date | Jan 4, 2017 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 1.26 |
| Piotroski F-Score | 4 |